my concern is how slow the burn Is and what cash they will need. Secondly is how soon the company will get cashflow positive.
That being said I think Xero didn’t make a profit until the SP was in the order of $60 - don’t quote me on that - but I know it was a lot.
for a large bio med company - our MC is the same as a month worth of corporate lunches. I hope we get to see how far this thing grows, a take over would be disappointing in some respects.
the company does need to show how the strategy is playing out. And sort out the invoice for $20M would they!
Price at posting:
$1.16 Sentiment: Buy Disclosure: Held
